The recent coverage in the media, including a BBC article discussing the potential of GLP-1 weight loss drugs to address obesity on a national scale, highlights both the opportunities and challenges these medications present. NICE’s decision to restrict access to these drugs raises important points about missed opportunities for public health and the economy. As […]
Why a Balanced Approach to Weight Loss Drugs Is Essential